Baird Downgrades Tenet Healthcare to Neutral, Lowers Price Target to $137

Benzinga · 6d ago
Baird analyst Michael Ha downgrades Tenet Healthcare (NYSE:THC) from Outperform to Neutral and lowers the price target from $153 to $137.